As of July 2025, NVIDIA (NVDA) is trading at $172.72 per share, once again reaching a historical high. With a market capitalization exceeding $4.2 trillion, it has cemented its place as the world’s most valuable semiconductor company. But despite the excitement, now might be the worst time to jump in.
1. Valuations at Record Highs
NVIDIA’s valuation metrics are flashing red across the board:
- NTM P/E (Next 12 Months Price/Earnings): 38.52x
- NTM EV/EBITDA: 31.46x
- NTM P/S (Price/Sales): 21.28x
- LTM P/E (Last 12 Months): 66.04x
- LTM EV/EBITDA: 55.98x
These multiples suggest that the stock is not just expensive — it’s priced for perfection. Any earnings miss or guidance disappointment could trigger a sharp correction.
2. Price Outpacing Earnings Growth
While NVIDIA’s stock has climbed from $113 to $172.72 over the past year (+53%), EBITDA has grown from $87.7B to $110.9B (+26%), and EBIT from $86.0B to $140.0B (+62%). Yes, earnings growth is solid — but the valuation expansion has far outpaced the fundamentals.
When a stock’s price climbs faster than its earnings, it often signals a euphoric market disconnected from reality.
3. Free Cash Flow Yield Indicates Overvaluation
- NTM Market Cap / Free Cash Flow: 44.23x
- NTM Levered Free Cash Flow Yield: 2.3%
To justify its current valuation, NVIDIA needs to maintain extremely high growth and profitability. However, rising competition in AI, geopolitical risks, and sticky U.S. interest rates all present real headwinds.
4. Investor Expectations Already Fully Priced In
Despite its meteoric rise, NVIDIA pays no dividend and trades at over 100x its net asset value per share. Even by aggressive growth stock standards, these levels are extremely stretched.
Bottom Line: This Is a Time for Caution, Not FOMO
NVIDIA is undeniably a top-tier company at the forefront of AI and GPU technology. But remember — a great company isn’t always a great investment at any price.
Buying at this level could easily lead to buying the top, exposing investors to significant downside. Sometimes, the best move is to wait — let the hype cool and the valuation normalize.